Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 6Papillomavirus Infections 4Uterine Cervical Dysplasia 3Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Spondylarthritis 1Ovarian Neoplasms 1Neoplasms 1Endometrial Neoplasms 1Atypical Squamous Cells of the Cervix 1

Interventions

Surveys and Questionnaires 114Exercise 103Blood Specimen Collection 99Radiotherapy 67Gemcitabine 64Bevacizumab 57Standard of Care 56Cisplatin 55Cyclophosphamide 51Capecitabine 50Carboplatin 49Docetaxel 47pembrolizumab 46Dexamethasone 46Paclitaxel 45Interviews as Topic 43Oxaliplatin 40Magnetic Resonance Spectroscopy 39Fluorouracil 37Methods 36Irinotecan 36Therapeutics 33Drug Therapy 33Radiosurgery 31Nivolumab 30Erlotinib Hydrochloride 27Educational Status 26Everolimus 24Leucovorin 23Control Groups 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplasms × Vaginal Smears × Clear all
NCT04859530 2025-01-29

Automated Cervical Cancer Screening Using a Smartphone-based Artificial Intelligence Classifier

University Hospital, Geneva

Phase NA Recruiting
5,886 enrolled
Gynecologic

Uterine Cervical Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡